Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

31.80
+0.40001.27%
Post-market: 31.800.00000.00%16:27 EDT
Volume:74.37K
Turnover:2.35M
Market Cap:125.23M
PE:-30.12
High:32.09
Open:31.15
Low:31.05
Close:31.40
52wk High:44.00
52wk Low:19.50
Shares:3.94M
Float Shares:2.42M
Volume Ratio:1.80
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:5.88
PE(LYR):-9.93

Loading ...

Vtv Therapeutics Inc : Btig Raises Target Price to $57 from $49

THOMSON REUTERS
·
Jul 16

Vtv Therapeutics Grants 12,500 Inducement Stock Options at Weighted Average Exercise Price of $34.15

Reuters
·
Jul 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

vTv Therapeutics Shareholders Approve Directors, Question Executive Pay

TIPRANKS
·
Jun 30

Vtv Therapeutics Holds Annual Shareholder Meeting

Reuters
·
Jun 30

vTv Therapeutics grants 2,500 inducement stock options at $34.3 per share

Reuters
·
Jun 03

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

H.C. Wainwright Sticks to Their Buy Rating for vTv Therapeutics (VTVT)

TIPRANKS
·
May 27

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT), Waters (WAT) and Alpha Teknova (TKNO)

TIPRANKS
·
May 14

Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program

TIPRANKS
·
May 14

vTv Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $45 From $47

THOMSON REUTERS
·
May 14

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and vTv Therapeutics (VTVT)

TIPRANKS
·
May 14

vTv Therapeutics Expands At-The-Market Share Program Capacity

TIPRANKS
·
May 14

vTv Therapeutics Inc - Increases Class a Common Stock Offered Under Atm Program to Full Amount - SEC Filing

THOMSON REUTERS
·
May 14

vTv Therapeutics boosts share capacity under at-the-market equity sales program

Reuters
·
May 14

vTv Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

vTv Therapeutics Q1 EPS $1.65 Beats $(0.10) Estimate, Sales $36.839M Beat $20.000M Estimate

Benzinga Earnings
·
May 14

vTv Therapeutics reports Q1 EPS $1.65, consensus 21c

TIPRANKS
·
May 14